Actualités Cayson Acquisition Corporation - CAPN | Actions NASDAQ

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration No. 333-215856 PROSPECTUS SUPPLEMENT NO...

Amended Current Report Filing (8-k/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Current Report Filing (8-k)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare, Inc.

REDWOOD CITY, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration No. 333-215856 PROSPE...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on July 13...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in Prader-Willi Syndrome

Positive guidance received on key elements of Phase III programCompany expects to initiate pivotal Phase...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on June 12...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration No. 333-215856 PROSPECTUS SUPPLEMENT NO...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration No. 333-215856 PROSPECTUS SUPPLEMENT NO...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration No. 333-215856 PROSPECTUS SUPPLEMENT NO...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cayson Acquisition Corporation (CAPN)

Votre Hub pour des idées et discussions en direct en temps réel

CAPN Actualités

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare, Inc.

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (s-1/a)

Current Report Filing (8-k)

Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in Prader-Willi Syndrome

Securities Registration Statement (s-1/a)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cayson Acquisition Corporation (CAPN) Actualités

Cayson Acquisition Corporation (CAPN)

Votre Hub pour des idées et discussions en direct en temps réel

CAPN Actualités

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Soleno Therapeutics Announces Sale of Non-Strategic Assets to Flexicare, Inc.

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (s-1/a)

Current Report Filing (8-k)

Soleno Therapeutics Announces Successful Completion of FDA Meeting for DCCR in Prader-Willi Syndrome

Securities Registration Statement (s-1/a)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application